Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 January 2007, Vol. 109, No. 1, pp. 11-21.
Prepublished online as a Blood First Edition Paper on August 29, 2006; DOI 10.1182/blood-2006-05-021188.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2006-05-021188v1
109/1/11    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Talebian, L.
Right arrow Articles by Speck, N. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Talebian, L.
Right arrow Articles by Speck, N. A.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted May 3, 2006
Accepted August 9, 2006

T lymphoid, megakaryocyte, and granulocyte development are sensitive to decreases in CBF{beta} dosage

Laleh Talebian, Zhe Li, Yalin Guo, Justin Gaudet, Maren E Speck, Daisuke Sugiyama, Prabhjot Kaur, Warren S. Pear, Ivan Maillard, and Nancy A. Speck*

Department of Biochemistry, Dartmouth Medical School, Hanover, NH, USA
Department of Pathology, Dartmouth Medical School, Hanover, NH, USA
Institute for Medicine & Engineering, University of Pennsylvania, Philadelphia, PA, USA
Division of Hematology-Oncology, University of Pennsylvania School of Medicine, Philadelphia,PA, USA

* Corresponding author; email: nancy.speck{at}dartmouth.edu.

The family of core binding factors includes the DNA- binding subunits Runx1-3 and their common non-DNA binding partner CBF{beta}. We examined the collective role of core binding factors in hematopoiesis with a hypomorphic Cbfb allelic series. Reducing CBF{beta} levels by three- or six-fold caused abnormalities in bone, megakaryocytes, granulocytes and T cells. T cell development was very sensitive to an incremental reduction of CBF{beta} levels: mature thymocytes were decreased in number upon a three-fold reduction in CBF{beta} levels, and were virtually absent when CBF{beta} levels were six-fold lower. Partially penetrant consecutive differentiation blocks were found amongst early T lineage progenitors within the CD4- CD8- double negative 1 and downstream double negative 2 thymocyte subsets. Our data define a critical CBF{beta} threshold for normal T cell development, and situate an essential role for core binding factors during the earliest stages of T cell development.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

The CBFB-MYH11 butterfly effect in hematopoiesis
Andre J. van Wijnen and Gary S. Stein
Blood 2007 109: 3131-3132. [Full Text] [PDF]





 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020